You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SBIR Phase I: Hybrid surgical stapler with tissue sensing technology

    SBC: RevMedica Inc.            Topic: MD

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to improve the current state of the art of surgical stapler devices. Despite their widespread adoption in surgical practices, stapler malfunctioning or misuse can cause severe surgical and post-surgical complications which include bleeding, sepsis, and death. Misfiring and cutting errors ar ...

    SBIR Phase I 2021 National Science Foundation
  2. SBIR Phase I: In vitro cultivation of sweet cherry

    SBC: POMODYNE INC            Topic: BT

    The broader impact of this Small Business Innovation Research (SBIR) Phase I project is to radically increase the efficiency of plant agriculture, with far-reaching implications for both humans and native ecosystems. Agricultural land productivity has increased approximately 3-fold in the past 60 years, due to a combination of crop breeding and genetic engineering, adoption of chemical fertilizers ...

    SBIR Phase I 2021 National Science Foundation
  3. SBIR Phase I: Quieting systemic hyper-inflammation (COVID-19)

    SBC: FIBROSIX INC.            Topic: PT

    The broader impact of this Small Business Innovation Research (SBIR) Phase I project is to alleviate the suffering caused by hyper-inflammation. Hyper-inflammation is a mis-regulation of the immune system often brought on by viral pneumonia. It can have severe life-threatening complications, including acute respiratory distress syndrome (ARDS) and changes in blood clotting; hyper-inflammation has ...

    SBIR Phase I 2021 National Science Foundation
  4. SBIR Phase I: CANCER DIAGNOSTIC TOOL USING CANCER GENOMIC SIGNATURES TO DETERMINE CANCER TYPE

    SBC: VYNANCE TECHNOLOGIES, LLC            Topic: DH

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop a data analytic tool to predict and identify the organ of origin from early cancer screening blood tests. This will allow noninvasive detection of cancer at early stages, when it can be treated with potentially improved outcomes and in a less costly manner. Second, a complementar ...

    SBIR Phase I 2021 National Science Foundation
  5. SBIR Phase I: Development of Continuous Micro Casting Deposition process for rotary targets manufacturing

    SBC: Junora Ltd            Topic: M

    The broader impact of this Small Business Innovation Research (SBIR) Phase 1 project will develop an innovative and efficient advanced manufacturing method to substantially reduce costs of thin coating processes. This innovation will lead to a significant reduction of production costs of goods such as energy-efficient and smart windows, solar panels, thin-film solid-state batteries, electronic dis ...

    SBIR Phase I 2021 National Science Foundation
  6. SBIR Phase I: Off-the-Shelf immuno-compatible cell therapies

    SBC: PROGENITOR INC.            Topic: BT

    The broader impact of this Small Business Innovation Research (SBIR) Phase I project is to improve cell therapy by enabling the rapid development of novel and safe therapies through the seamless production of pre-characterized, good manufacturing practice (GMP) grade, universally immune-compatible induced pluripotent stem cell (iPSC) cell lines. The solution will target the global cell therapy mar ...

    SBIR Phase I 2021 National Science Foundation
  7. SBIR Phase I: Artificial Intelligence (AI) Enabled 3-Dimensional (3D) Imaging for COVID-19

    SBC: NVIEW MEDICAL            Topic: R

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to improve COVID-19 treatments by providing imaging information to assess the severity and progression of the disease. Chest computed tomography (CT) has been shown to be sensitive to COVID-19 via the observation of ground-glass opacities and is being used on patients with acute symptoms. P ...

    SBIR Phase I 2021 National Science Foundation
  8. SBIR Phase I: Dynamic Night Splint

    SBC: Kenai Design, LLC            Topic: MD

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is improved care for plantar fasciitis (PF), an inflammation of the fibrous tissue (plantar fascia) along the bottom of the foot connecting the heel bone to the toes. This progressive degenerative condition results in stabbing, sometimes debilitating, pain. Plantar fasciitis is most common in ...

    SBIR Phase I 2021 National Science Foundation
  9. SBIR Phase I: Rapid Development of a Protein Vaccine for COVID-19

    SBC: OMNICYTE LLC            Topic: PT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of a vaccine to prevent infection from the SARS-CoV-2 virus. The proposed project is a novel vaccine that activates multiple components of the immune system, potentially more effective than other SAR-CoV-2 vaccines, and using a well-understood approach as a protein-based vac ...

    SBIR Phase I 2021 National Science Foundation
  10. SBIR Phase I: Novel injectable long-acting local anesthetic for postoperative pain management

    SBC: 109 Therapeutics, Inc.            Topic: BM

    The broader impact /commercial potential of this Small Business Innovation Research (SBIR) Phase I project develops novel pain therapeutics that can reduce or eliminate the use of opioids after surgery. Opioid-based medications are a mainstay of postopera

    SBIR Phase I 2020 National Science Foundation
US Flag An Official Website of the United States Government